Total Payments
$2,310
2024 Payments
$451.61
Companies
28
Transactions
126
Medicare Patients
380
Medicare Billing
$38,676
Payment Breakdown by Category
Food & Beverage$2,295 (99.4%)
Education$14.50 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,295 | 125 | 99.4% |
| Education | $14.50 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $595.77 | 25 | $0 (2024) |
| Gilead Sciences, Inc. | $187.07 | 7 | $0 (2024) |
| Madrigal Pharmaceuticals | $162.52 | 4 | $0 (2024) |
| Allergan Inc. | $131.76 | 7 | $0 (2018) |
| Ferring Pharmaceuticals Inc. | $125.34 | 9 | $0 (2017) |
| Janssen Biotech, Inc. | $113.68 | 8 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $106.71 | 8 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $105.52 | 12 | $0 (2017) |
| Daiichi Sankyo Inc. | $83.41 | 5 | $0 (2018) |
| Merck Sharp & Dohme LLC | $73.71 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $451.61 | 18 | Madrigal Pharmaceuticals ($162.52) |
| 2022 | $54.37 | 3 | PFIZER INC. ($20.82) |
| 2021 | $23.99 | 2 | AbbVie Inc. ($23.99) |
| 2020 | $23.97 | 1 | AbbVie Inc. ($23.97) |
| 2019 | $35.51 | 2 | Janssen Biotech, Inc. ($20.66) |
| 2018 | $350.86 | 16 | AbbVie, Inc. ($114.43) |
| 2017 | $1,369 | 84 | AbbVie, Inc. ($359.83) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: LIVER DISEASE | ||||||
| 12/13/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $22.24 | General |
| Category: Elastography | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $114.39 | General |
| Category: LIVER DISEASE | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/06/2024 | Olympus America Inc. | EndoClot PHS (Device) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Endotherapy | ||||||
| 10/30/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: LIVER DISEASE | ||||||
| 10/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Immunology | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: LIVER DISEASE | ||||||
| 09/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.27 | General |
| 08/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/26/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/23/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: VACCINES | ||||||
| 02/02/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: IMMUNOLOGY | ||||||
| 07/20/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: IMMUNOLOGY | ||||||
| 07/29/2020 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 127 | 129 | $102,744 | $13,519 |
| 2022 | 6 | 120 | 121 | $88,385 | $12,626 |
| 2021 | 5 | 78 | 80 | $57,458 | $8,047 |
| 2020 | 3 | 55 | 56 | $28,905 | $4,484 |
Total Patients
380
Total Services
386
Medicare Billing
$38,676
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 24 | 24 | $30,984 | $4,325 | 14.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 38 | $27,930 | $2,788 | 10.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $11,620 | $2,383 | 20.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,928 | $1,369 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $4,830 | $1,029 | 21.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $7,716 | $1,027 | 13.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $14,736 | $598.18 | 4.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 22 | 22 | $24,816 | $3,513 | 14.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 34 | 34 | $24,990 | $2,670 | 10.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $9,960 | $2,137 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $6,859 | $1,965 | 28.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $18,000 | $1,193 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 15 | 16 | $3,760 | $1,148 | 30.5% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 14 | 14 | $15,792 | $2,894 | 18.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 22 | 22 | $16,170 | $1,870 | 11.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 15 | $3,525 | $1,259 | 35.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $3,971 | $1,146 | 28.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 18 | 18 | $18,000 | $877.98 | 4.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 28 | 28 | $20,580 | $2,568 | 12.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 15 | 16 | $3,843 | $998.56 | 26.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $4,482 | $917.02 | 20.5% |
About Dr. Kimberly Dalmau, M.D
Dr. Kimberly Dalmau, M.D is a Gastroenterology healthcare provider based in Slidell, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104923770.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kimberly Dalmau, M.D has received a total of $2,310 in payments from pharmaceutical and medical device companies, with $451.61 received in 2024. These payments were reported across 126 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,295).
As a Medicare-enrolled provider, Dalmau has provided services to 380 Medicare beneficiaries, totaling 386 services with total Medicare billing of $38,676. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine
- Location Slidell, LA
- Active Since 09/17/2006
- Last Updated 09/11/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1104923770
Products in Payments
- Humira (Biological) $283.87
- LINZESS (Drug) $170.86
- RESMETIROM (Drug) $162.52
- PREPOPIK (Drug) $125.34
- Epclusa (Drug) $125.00
- Amitiza (Drug) $87.09
- STELARA (Biological) $72.73
- SUPREP (Drug) $72.32
- DUPIXENT (Biological) $70.37
- MOVIPREP (Drug) $57.08
- HUMIRA (Biological) $55.32
- DIFICID (Drug) $51.02
- Entyvio (Biological) $50.59
- ZENPEP (Drug) $48.21
- Movantik (Drug) $44.49
- VOQUEZNA (Drug) $44.44
- Sucraid (Drug) $43.52
- CREON (Drug) $39.69
- INJECTAFER (Drug) $38.92
- Omeclamox (Drug) $36.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Slidell
Edward Dauterive, M.d, M.D
Gastroenterology — Payments: $63,459
Gastroenterology $63,459
Anthony Albright, M.d, M.D
Gastroenterology — Payments: $22,879
Gastroenterology $22,879
Veronica Dugan, M.d, M.D
Gastroenterology — Payments: $18,530
Gastroenterology $18,530
Timothy Trainor, M.d, M.D
Gastroenterology — Payments: $14,155
Gastroenterology $14,155
Dasarathy Srinivas, M.d, M.D
Gastroenterology — Payments: $1,456
Gastroenterology $1,456
Malcolm Andry, M.d, M.D
Gastroenterology — Payments: $205.02
Gastroenterology $205.02